Terms: = Kidney tumors AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Treatment
11 results:
1. Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
Schoenfeld DA; Moutafi M; Martinez S; Djureinovic D; Merkin RD; Adeniran A; Braun DA; Signoretti S; Choueiri TK; Parisi F; Hurwitz M; Rimm DL; Wei W; Jilaveanu L; Kluger HM
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586773
[TBL] [Abstract] [Full Text] [Related]
2. Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.
Lee MH; Theodoropoulos J; Huuhtanen J; Bhattacharya D; Järvinen P; Tornberg S; Nísen H; Mirtti T; Uski I; Kumari A; Peltonen K; Draghi A; Donia M; Kreutzman A; Mustjoki S
Cancer Res Commun; 2023 Jul; 3(7):1260-1276. PubMed ID: 37484198
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.
Lv S; Tao L; Liao H; Huang Z; Lu Y
Funct Integr Genomics; 2023 Jun; 23(2):193. PubMed ID: 37264263
[TBL] [Abstract] [Full Text] [Related]
4. Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.
Stoltze UK; Hildonen M; Hansen TVO; Foss-Skiftesvik J; Byrjalsen A; Lundsgaard M; Pignata L; Grønskov K; Tumer Z; Schmiegelow K; Brok JS; Wadt KAW
J Med Genet; 2023 Sep; 60(9):842-849. PubMed ID: 37019617
[TBL] [Abstract] [Full Text] [Related]
5. Thymic function, anti-thymocytes globulins, and cancer after renal transplantation.
Ducloux D; Bamoulid J; Courivaud C; Gaugler B; Rebibou JM; Ferrand C; Chalopin JM; Borg C; Tiberghien P; Saas P
Transpl Immunol; 2011 Jul; 25(1):56-60. PubMed ID: 21620972
[TBL] [Abstract] [Full Text] [Related]
6. Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.
Desar IM; Jacobs JH; Hulsbergen-vandeKaa CA; Oyen WJ; Mulders PF; van der Graaf WT; Adema GJ; van Herpen CM; de Vries IJ
Int J Cancer; 2011 Jul; 129(2):507-12. PubMed ID: 20839259
[TBL] [Abstract] [Full Text] [Related]
7. Frequency and gene expression profile of regulatory T cells in renal cell carcinoma.
Jeron A; Pfoertner S; Bruder D; Geffers R; Hammerer P; Hofmann R; Buer J; Schrader AJ
Tumour Biol; 2009; 30(3):160-70. PubMed ID: 19609102
[TBL] [Abstract] [Full Text] [Related]
8. LINAC radiosurgery for brain metastasis of renal cell carcinoma.
Noel G; Valery CA; Boisserie G; Cornu P; Hasboun D; Marc Simon J; Tep B; Ledu D; Delattre JY; Marsault C; Baillet F; Mazeron JJ
Urol Oncol; 2004; 22(1):25-31. PubMed ID: 14969800
[TBL] [Abstract] [Full Text] [Related]
9. Preliminary experience with cryoablation of renal lesions smaller than 4 centimeters.
Khorsandi M; Foy RC; Chong W; Hoenig DM; Cohen JK; Rukstalis DB
J Am Osteopath Assoc; 2002 May; 102(5):277-81. PubMed ID: 12033757
[TBL] [Abstract] [Full Text] [Related]
10. High-dose toremifene in advanced renal-cell carcinoma.
Gershanovich MM; Moiseyenko VM; Vorobjev AV; Käpylä H; Ellmén J; Anttila M
Cancer Chemother Pharmacol; 1997; 39(6):547-51. PubMed ID: 9118468
[TBL] [Abstract] [Full Text] [Related]
11. [Hormone therapy of advanced renal cancer with high-dose toremifene (Fareston)].
Gershanovich ML; Moiseenko VM; Vorob'ev AV; Kiapiulia K
Vopr Onkol; 1996; 42(5):105-9. PubMed ID: 9064893
[TBL] [Abstract] [Full Text] [Related]